Tag Archives: tumor

See something, do something

Dr Sue Ettinger is on a mission to help pet owners detect tumors early.  Her inspiration for this new program, called See Something, Do Something, was a 10-year old white pit bull named Smokey.

Smokey

Smokey

Dr Ettinger had aspirated approximately 10 masses from Smokey over the years and all came back as benign; so she wasn’t particularly worried when Smokey presented with another lump.  The clinic was so busy on the day he came in with his vet tech owner, that he never got tested that day and waited another week before returning to the clinic.

When it was aspirated, it wasn’t a lipoma and testing revealed a soft tissue sarcoma.  It hadn’t spread to other parts of the body, but a 7 cm mass with 3 cm margins was a very big surgery; they got it all and so Smokey was out of the woods.

But Dr Ettinger combed through literature to find out if there were guidelines for vets and owners about diagnosing lumps and bumps.  There weren’t and she decided to take action.

So she’s come up with:

See Something?  If a dog or cat has had a lump that is larger than a pea and has been there for more than a month…

Do Something! Go to a vet and get it aspirated or biopsied.

and even a shorter call to action:  Why Wait? Aspirate!

Simple rules that could save the life of your pet and also avoid needless pain and suffering.

Sue Ettinger is one of approximately 300 board-certified veterinary specialists in medical oncology in North America. Dr Sue is a staff oncologist and initiated the medical oncology service at the Animal Specialty Center (ASC), a private practice specialty hospital in Westchester, just north of New York City.

Sue Ettinger is one of approximately 300 board-certified veterinary specialists in medical oncology in North America. Dr Sue is a staff oncologist and initiated the medical oncology service at the Animal Specialty Center (ASC), a private practice specialty hospital in Westchester, just north of New York City

Kathleen Crisley, Fear-Free certified professional and specialist in dog massage, rehabilitation and nutrition/food therapy, The Balanced Dog, Christchurch, New Zealand

Treating canine cancer with nanotechnology

An 11-year-old Labradoodle named Grayton  is the first patient at the Virginia-Maryland College of Veterinary Medicine in a new clinical trial that is testing the use of gold nanoparticles and a targeted laser treatment for solid tumors in dogs and cats.

Grayton is suffering from a return of nasal adenocarcinoma, a cancer of the nasal passages that typically has a short life expectancy.  (Grayton’s tumor was originally treated with high dose radiation which extended his life by three years.)

Dr. Shawna Klahn, assistant professor of oncology in the Department of Small Animal Clinical Sciences, performs a checkup on Grayton four weeks after his experimental cancer treatment involving gold nanoparticles and a targeted laser therapy. (photo courtesy of Virginia Tech News)

Dr. Shawna Klahn, assistant professor of oncology in the Department of Small Animal Clinical Sciences, performs a checkup on Grayton four weeks after his experimental cancer treatment involving gold nanoparticles and a targeted laser therapy. (photo courtesy of Virginia Tech News)

“This (nanotechnology) treatment involves two phases,” Dr. Nick Dervisis, assistant professor of oncology in the Department of Small Animal Clinical Sciences, said. “First, we infuse the patient with the gold nanoparticles. Although the nanoparticles distribute throughout the body, they tend to concentrate around blood vessels associated with tumors. Within 36 hours, they have cleared the bloodstream except for tumors. The gold nanoparticles are small enough to circulate freely in the bloodstream and become temporarily captured within the incomplete blood vessel walls common in solid tumors. Then, we use a non-ablative laser on the patient.”

Dervisis explained that a non-ablative laser is not strong enough to harm the skin or normal tissue, but “it does cause the remaining nanoparticles to absorb the laser energy and convert it into heat so that they damage the tumor cells.”

Like all clinical trials, the study involves many unknowns, including the treatment’s usefulness and effectiveness. One month after the AuroLase treatment, the nosebleeds that initially brought Grayton back to the Veterinary Teaching Hospital had stopped and Grayton has no other side effects.

Grayton’s owners report that he recently enjoyed the family’s summer vacation at the beach.

Grayton may be the first companion animal in the study at the veterinary college, but he certainly won’t be the last. Dervisis is continuing to enroll patients in the study and is seeking dogs and cats of a certain size with solid tumors who have not recently received radiation therapy or chemotherapy. For more information about the trial and eligibility requirements, owners should visit the Veterinary Clinical Research Office website.

Source:  Media release, Virginia Tech News